PursueCare to Showcase Digital-First Addiction Treatment and Collaborative Care Models at 2025 Behavioral Health Business Addiction Treatment Forum in Chicago
Available across Connecticut, Kentucky, Massachusetts, Maine, Ohio, and West Virginia, PursueCare delivers comprehensive, virtual-first SUD care that bridges the gaps in access and continuity of care.
Share
Nicholas Mercadante, Founder and CEO of PursueCare, will join the expert panel titled 'Who's at Quarterback? Ensuring Smooth SUD Handoffs and Building the Partnership Playbook,' slated for 11:30 a.m. CDT. Mercadante will discuss the critical importance of integrated care models and effective handoffs in SUD treatment, drawing on his experience leading a tech-enabled platform designed to meet patients where they are—with convenience, compassion, and clinical excellence.
As a former healthcare attorney turned entrepreneur, Mercadante founded PursueCare with a mission to dismantle barriers to addiction treatment by leveraging technology, innovative care delivery, and cross-sector partnerships. Under his leadership, PursueCare has become a leading voice in redefining how providers, payors, and care networks collaborate to treat SUDs holistically. 'Everyone of us at PursueCare is committed to value-based care, our team is dedicated to serving patients in need and shaping industry standards around quality, accessibility, and equity.'
Innovation in Action: How PursueCare Is Transforming Addiction Treatment
PursueCare delivers comprehensive, virtual-first SUD care that bridges the gaps in access and continuity of care. Available across Connecticut, Kentucky, Massachusetts, Maine, Ohio, and West Virginia, the platform offers:
Multidisciplinary care teams include addiction medicine providers, counselors, psychiatrists, and pharmacists.
FDA-authorized digital therapeutics — RESET ® and RESET-O ® —that support recovery 24/7 through interactive cognitive behavioral therapy.
Integrated pharmacy and lab services through PursueCareRx, enabling seamless medication management and compliance monitoring.
Flexible access through a HIPAA-compliant app with support for both scheduled and on-demand visits.
Broad insurance acceptance, including Medicare, Medicaid, and most private plans.
Mercadante will share the virtual clinic's approach to forging strong partnerships with health systems, employers, and value-based care organizations—offering seamless care coordination, real-time engagement, and outcome-driven models that empower both patients and partners. He'll be joined by fellow industry pioneers Jamie Vinck, President of Meadows Behavioral Health; Beth Keeney, CEO of LifeSpring Health Systems; and Dr. Ayesha Appa, Assistant Professor of Medicine at the University of California, San Francisco.
The BHB Forum will offer behavioral health professionals the opportunity to connect, collaborate, and learn from leaders and innovators across the industry. Attendees will include behavioral health professionals, investors, creators, and a range of vendors and service providers.
About PursueCare
PursueCare provides personalized virtual addiction treatment for individuals across states (CT, KY, MA, ME, OH, and WV). Our mission is to increase access to chronic care through telehealth. Patients engage with a multi-disciplinary team providing medical care, counseling, psychiatry, and pharmacy. FDA-authorized digital cognitive behavioral therapy, RESET ® and RESET-O ®, supports recovery 24/7. We accept private insurance, Medicare, and Medicaid.
For full disclaimers please visit .
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
36 minutes ago
- Axios
DOGE makes its way into biotech IPO filings
DOGE cuts are leading to new warnings in filings from biotech and health-care companies looking to IPO stateside. The big picture: Uncertainty is a deal killer. According to data from Renaissance Capital, there have been just four biotech IPOs this year that have raised over $50 million — down from 10 in the same period last year. Venture bets are slowing too. Driving the news: Carlsmed, a personalized spine surgery company backed by B Capital Group and U.S. Venture Partners warned in its prospectus that "the current U.S. presidential administration" has issued policies to cut headcount and budgets in agencies including the FDA. "It remains unclear the degree to which these efforts may limit or otherwise adversely affect the FDA's ability to conduct routine activities," it continued. Sixth Street-backed cancer diagnostics company, Caris Life Sciences, which went public in late June, said this: "The current Trump administration is pursuing policies to reduce regulations and expenditures across government including at HHS, the FDA, CMS, and related agencies," Caris' prospectus read. "These actions ... may propose policy changes that create additional uncertainty for our business. Zoom out: Though Carlsmed says it's "unclear the degree to which" the cuts will affect the FDA's ability to conduct routine activity, those in the space already feel the effects. The FDA told KalVista Pharmaceuticals last month that the agency would miss a deadline in approving a drug for potentially life-threatening genetic disorders — marking what appears to be the first time a review had to be extended over DOGE cuts. Verve Therapeutics, in a filing explaining its rationale for selling to Eli Lilly for $1.3 billion, noted that Peter Marks resignation in March as director of the FDA played a role in its move to sell rather than raise additional capital.
Yahoo
an hour ago
- Yahoo
Ritz Crackers are Being Recalled Nationwide for This Life-Threatening Reason—Here's What to Know
Ritz Crackers are Being Recalled Nationwide for This Life-Threatening Reason—Here's What to Know originally appeared on Parade. Product recalls are never good news. But when they happen, it's on us as consumers to check our kitchens and make sure the foods we're eating aren't part of an affected batch. Recalls can be issued for all kinds of reasons—but faulty packaging, contamination or missing ingredients on a label are some of the most common ones. On July 8, Mondelēz Global LLC announced a voluntary recall of four carton sizes of RITZ Peanut Butter Cracker Sandwiches. The affected products were made in the U.S. and sold to the FDA notice, the recall includes 8-pack, 20-pack and 40-pack cartons of RITZ Peanut Butter Cracker Sandwiches, as well as the 20-pack RITZ Filled Cracker Sandwich Variety Pack. The issue? Some individually wrapped packs may be mislabeled as the Cheese variety, even though they actually contain the Peanut Butter variety. It's important to note that anyone with a peanut allergy or severe sensitivity could be at risk of a serious—or even life-threatening—allergic reaction if they consume these products. However, the FDA clarified that all affected outer cartons are labeled correctly and include an allergen advisory stating the product 'contains peanuts.' To help you identify the products at home, you can find full product descriptions, 'Best When Used By' dates and UPC codes here, as well as affected product images here. You can also locate a breakdown of what the product info grid might look like on the incorrectly labeled individually wrapped packages to the notice, this is a precautionary recall. No other RITZ products or Mondelēz Global LLC products are affected, and in a huge relief, there have been zero reports of injury or illness linked to it. The recall was initiated after Mondelēz Global LLC discovered that film packaging rolls used for individually wrapped peanut butter products may have defects due to a supplier error. According to the notice, 'corrective actions are being taken to help ensure this issue does not recur.' Just to be clear, cartons with only RITZ Cheese Cracker Sandwiches are not part of this recall. And if your RITZ Peanut Butter or RITZ Filled Cracker Sandwich Variety Pack has a different 'Best When Used By' date or plant code than the ones listed here, you're safe. If you have a peanut allergy, it's recommended to discard any of the affected products immediately or return them to the place of purchase for a refund. You can call the company anytime at 1-844-366-1171, or reach a Consumer Relations specialist Monday through Friday, 9 am to 6 pm Crackers are Being Recalled Nationwide for This Life-Threatening Reason—Here's What to Know first appeared on Parade on Jul 9, 2025 This story was originally reported by Parade on Jul 9, 2025, where it first appeared.
Yahoo
an hour ago
- Yahoo
This Popular Cheese Product Is Being Recalled For a Very Serious Reason—Here's What to Know
This Popular Cheese Product Is Being Recalled For a Very Serious Reason—Here's What to Know originally appeared on Parade. Food recalls are never a fun experience. As consumers, we're forced to check our labels carefully, and if we have the recalled item in our possession, we either return it for a refund or discard it completely. But not every food safety issue starts as a full-fledged recall. This week, for example, the U.S. Food and Drug Administration (FDA) announced a recall of a select batch of Boar's Head deli products—though the agency has yet to classify the severity. 😋😋SIGN UP to get delicious recipes, handy kitchen hacks & more in our daily Pop Kitchen newsletter🍳🍔 According to the official notice, 65 cases, roughly amounting to 780 packages (each carrying 12 8-ounce packages) of Boar's Head Smoked Gouda cheese were distributed despite having a mislabeling issue. The recalled cheese products were produced by the Alpine Slicing and Cheese Conversion Company out of Wisconsin, and distributed to stores in the state of Florida. For those out of the loop with recalls, a mislabeling issue can mean a number of things. At worst, it involves the omission of a major allergen or ingredient from the label—posing serious health risks for people with food allergies or dietary restrictions. At best, it's a less serious error, like a mislabeled flavor or an inaccurate photo on the packaging, which doesn't pose a danger but still warrants a recall to uphold consumer transparency and company standards. While the severity of the recall is still being determined, and no further information about the mislabeling has been provided, it's reassuring that the issue is limited to one state. The recalled cheese was sold in 8-ounce packages and found in most major store refrigerators. It does not affect Boar's Head Smoked Gouda sliced at the deli counter, and no other products have been you think you have a package of Boar's Head Smoked Gouda Cheese at home, check for UPC 0 42421-50006 6, code 03 SEP 25 F, and 'Distributed by Brunckhorst Co., NY, NY 11206." While the recall has not yet been officially classified, the FDA advises consumers not to eat the product out of an abundance of caution—either throw it away or return it to the place of purchase for a full refund. Otherwise, as the issue progresses and more information becomes available, we'll report back to keep things up to date. The last thing anyone wants is to kick off the summer with a foodborne illness—or worse, for someone with an allergy to have a serious reaction to something that could've been Popular Cheese Product Is Being Recalled For a Very Serious Reason—Here's What to Know first appeared on Parade on Jul 14, 2025 This story was originally reported by Parade on Jul 14, 2025, where it first appeared.
